Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease: Results From the Trial to Assess Chelation Therapy Randomized Trial.

Mark DB, Anstrom KJ, Clapp-Channing NE, Knight JD, Boineau R, Goertz C, Rozema TC, Liu DM, Nahin RL, Rosenberg Y, Drisko J, Lee KL, Lamas GA; of the TACT Investigators.

Circ Cardiovasc Qual Outcomes. 2014 Jul 1. pii: CIRCOUTCOMES.114.000977. [Epub ahead of print]

PMID:
24987051
[PubMed - as supplied by publisher]
2.

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

Al-Khatib SM, Hellkamp AS, Fonarow GC, Mark DB, Curtis LH, Hernandez AF, Anstrom KJ, Peterson ED, Sanders GD, Al-Khalidi HR, Hammill BG, Heidenreich PA, Hammill SC.

JAMA. 2014 Jun 4;311(21):2209-15. doi: 10.1001/jama.2014.5310.

PMID:
24893088
[PubMed - indexed for MEDLINE]
3.

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G.

N Engl J Med. 2014 May 29;370(22):2093-101. doi: 10.1056/NEJMoa1401739. Epub 2014 May 18.

PMID:
24836309
[PubMed - indexed for MEDLINE]
4.

Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocol.

Miller TE, Thacker JK, White WD, Mantyh C, Migaly J, Jin J, Roche AM, Eisenstein EL, Edwards R, Anstrom KJ, Moon RE, Gan TJ; Enhanced Recovery Study Group.

Anesth Analg. 2014 May;118(5):1052-61. doi: 10.1213/ANE.0000000000000206.

PMID:
24781574
[PubMed - indexed for MEDLINE]
5.

Factors associated with the change in prevalence of cardiomyopathy at delivery in the period 2000-2009: a population-based prevalence study.

Grotegut C, Kuklina E, Anstrom K, Heine R, Callaghan W, Myers E, James A.

BJOG. 2014 Mar 25. doi: 10.1111/1471-0528.12726. [Epub ahead of print]

PMID:
24661593
[PubMed - as supplied by publisher]
6.

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.

Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G; IPFnet Investigators.

Lancet Respir Med. 2013 Jul;1(5):369-76. doi: 10.1016/S2213-2600(13)70105-X. Epub 2013 Jun 14.

PMID:
24429201
[PubMed - in process]
Free PMC Article
7.

Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.

Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM; NHLBI Heart Failure Clinical Research Network.

JAMA. 2013 Dec 18;310(23):2533-43. doi: 10.1001/jama.2013.282190.

PMID:
24247300
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE Jr, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP.

Am J Respir Crit Care Med. 2014 Jan 15;189(2):214-22. doi: 10.1164/rccm.201306-1141WS.

PMID:
24160862
[PubMed - indexed for MEDLINE]
9.

Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, Hernandez AF, Lee KL, Braunwald E, Redfield MM; Heart Failure Clinical Research Network.

Circ Heart Fail. 2013 Sep 1;6(5):1087-94. doi: 10.1161/CIRCHEARTFAILURE.113.000347. No abstract available.

PMID:
24046475
[PubMed - indexed for MEDLINE]
10.

Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).

Hess CN, Rao SV, Kong DF, Aberle LH, Anstrom KJ, Gibson CM, Gilchrist IC, Jacobs AK, Jolly SS, Mehran R, Messenger JC, Newby LK, Waksman R, Krucoff MW.

Am Heart J. 2013 Sep;166(3):421-8. doi: 10.1016/j.ahj.2013.06.013. Epub 2013 Jul 23.

PMID:
24016489
[PubMed - indexed for MEDLINE]
11.

Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.

Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakayan A, Booth ME, Douglas PS, Messenger JC.

Catheter Cardiovasc Interv. 2014 Feb 1;83(2):171-81. doi: 10.1002/ccd.25108. Epub 2013 Aug 31.

PMID:
23907981
[PubMed - in process]
12.

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.

Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C; IPFnet investigators.

Respir Res. 2013 Jul 13;14:73. doi: 10.1186/1465-9921-14-73.

PMID:
23848435
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.

Han MK, Bach DS, Hagan PG, Yow E, Flaherty KR, Toews GB, Anstrom KJ, Martinez FJ; IPFnet Investigators.

Chest. 2013 Jun;143(6):1699-708. doi: 10.1378/chest.12-1594.

PMID:
23732584
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.

Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE Jr, Martinez FJ, Brown KK.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1272. doi: 10.1164/rccm.201304-0712LE. No abstract available.

PMID:
23725623
[PubMed - indexed for MEDLINE]
15.

Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms.

Eisenstein EL, Davidson-Ray L, Edwards R, Anstrom KJ, Ouriel K.

J Vasc Surg. 2013 Aug;58(2):302-10. doi: 10.1016/j.jvs.2013.01.038. Epub 2013 Apr 4.

PMID:
23562339
[PubMed - indexed for MEDLINE]
16.

Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.

Kumar RS, Douglas PS, Peterson ED, Anstrom KJ, Dai D, Brennan JM, Hui PY, Booth ME, Messenger JC, Shaw RE.

Circulation. 2013 Apr 2;127(13):1395-403. doi: 10.1161/CIRCULATIONAHA.113.001437.

PMID:
23547179
[PubMed - indexed for MEDLINE]
Free Article
17.

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E; RELAX Trial.

JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.

PMID:
23478662
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.

Hess CN, Rao SV, Kong DF, Miller JM, Anstrom KJ, Bertrand OF, Collet JP, Effron MB, Eloff BC, Fadiran EO, Farb A, Gilchrist IC, Holmes DR, Jacobs AK, Kaul P, Newby LK, Rutledge DR, Tavris DR, Tsai TT, White RM, Peterson ED, Krucoff MW.

Am Heart J. 2013 Mar;165(3):344-53.e1. doi: 10.1016/j.ahj.2012.09.008.

PMID:
23453103
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Decision support for evidence-based pharmacotherapy detects adherence problems but does not impact medication use.

Willis JM, Edwards R, Anstrom KJ, Johnson FS, Del Fiol G, Kawamoto K, Lapointe NM, Eisenstein EL, Lobach DF.

Stud Health Technol Inform. 2013;183:116-25.

PMID:
23388267
[PubMed - indexed for MEDLINE]
20.

Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.

Dewitt EM, Li Y, Curtis JR, Glick HA, Greenberg JD, Anstrom KJ, Kremer JM, Reed G, Schulman KA, Reed SD.

J Rheumatol. 2013 Feb;40(2):127-36. doi: 10.3899/jrheum.120400. Epub 2013 Jan 15.

PMID:
23322461
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk